Health committee  When we did the survey of companies, they told us that within a six-year period they normally change their labels anyway, regardless of whether there are any other requirements or new regulations in place. That's why there's a six-year period to phase in. There is no recall of products, so the enforcement is at the level of manufacturing.

Health committee  Certainly, in terms of the development of policy, it's not one person at all who makes those decisions and puts forth those policies. Again, it's entire groups of scientists, experts in policy and legal experts who come together to bring forth that policy. That policy is then shared publicly for open discussion.

Health committee  Thank you, Mr. Chair. Excuse my voice. I'm at the tail end of a cold. I'm COVID-negative times five, including this morning, just to let you know. Absolutely, in terms of the regulation-making process, there are a number of checks and balances, and we've gone through this with a number of files.

Health committee  Chair, I'm not sure we're here to propose alternatives to amendments, but I'll ask that as a process question.

Health committee  One thousand per cent I agree that we need to have those trends, and I could not agree with you more with respect to the importance of monitoring those and that this is one factor. We have a healthy living strategy. We have a healthy eating strategy. Absolutely even dietary preferences and scope are...it's multifactorial.

Health committee  Is there clarity in terms of which decisions you're asking about?

Health committee  There are definitely parameters that have been used for these types of interventions before. If you have something that's targeted to advertising these certain foods to this age group, and then you measure from now how much of that advertising is there that's targeted to that age group, it's something that's measurable that's directly related to the intervention.

Health committee  By doing monitoring, absolutely, we're looking at trends. The question is how you point to something, one specific thing, and say is that.... Again, the way that it's phrased is for proposed sections 7.1 and 7.2, have they been effective? These measures in five years will not be able to tell you that.

Health committee  It's that, and I would even go a step further and say that, if we are putting aside the implementation time and magically putting all of these interventions in tomorrow and starting to measure from that time period, even if we did that in five years, given the types of outcomes from a public health perspective, it would be really challenging to be able to demonstrate that in that period of time.

Health committee  Yes, there are a number of avenues we use to collect that data, the children's health survey being one of them. All of these parameters—illnesses, health outcomes, obesity, etc.—are being measured. I think the issue here is specifically saying that a review of the bill and the parameters, in this short period of time, for these types of things, would not be effective.

Health committee  As with everyone else, of course, any time there's new legislation and regulations put in place we want to make sure that we have a review process and measurable outcomes we can look at. In the longer term, absolutely, things like obesity, hypertension and chronic disease are things that we would want to monitor.

Health committee  It would still be challenging. Again, all those things that we're looking at in that list are multifactorial. There are lots of different things that can affect them. Those trends will continue and they'll move on. The question would be.... For this intervention, which we would measure from the time that it would be put in place to five years after, you have time for implementation and those things to take effect and then be able to see those trends in children.

Health committee  Perhaps, Mr. Chair, if I could also add.... Some of it is also based on the logistics of the datasets and the surveillance that is being done. A lot of the categories do include, when you're looking at the monitoring of advertising, the group between 13 and 17. It also helps, in terms of the parliamentary review process that will happen in five years, to collect data that then is comparable to data that we have as well, if we include 13-year-olds to 17-year-olds.

Health committee  To add from experience in other international jurisdictions, for example, when limitations were made on advertising during certain hours, there were then increases of advertising just outside of those hours as well. We know that teenagers are also vulnerable to advertising. As Mr.

Health committee  The intent at the level of the act is not really speaking to place. It's really about directed advertising, targeting certain age groups. Certainly, in the teenage population, the bulk of what teenagers would see in that type of advertising tends to be television or online. That's really the intent.